If you made any changes in Pure these will be visible here soon.

Personal profile

Personal information

Mark has a background in Biomedical Sciences and Health Technology Assessment (BSc, Radboudumc) as well as in Management and Entrepreneurship in the Life Sciences (MSc, Vrije Universiteit). As a PhD researcher, he analyzes the dynamics of intangible resources and intellectual property (IP) rights in Life Sciences industries. Mobilizing these hidden company assets for technological innovation and stakeholder value creation is at the center of his research.

 

 

 

Ancillary activities

No ancillary activities

Ancillary activities are updated daily

Education/Academic qualification

Biomedical Sciences (Health Technology Assessment), Bachelor, RadboudUMC

Management and Entrepreneurship in Health and Life Sciences, Master, Vrije Universiteit Amsterdam

Keywords

  • T201 Patents. Trademarks
  • HD28 Management. Industrial Management
  • innovation management
  • Science and Technology Studies
  • RA0421 Public health. Hygiene. Preventive Medicine
  • outbreak management
  • vaccine innovation
  • RM Therapeutics. Pharmacology
  • clinical trial management

Fingerprint Dive into the research topics where Mark van der Waal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Probiotics Medicine & Life Sciences
probiotics Agriculture & Biology
Microbiota Medicine & Life Sciences
Lactobacillus rhamnosus Medicine & Life Sciences
Insurance Benefits Medicine & Life Sciences
constipation Agriculture & Biology
food matrix Agriculture & Biology
product development Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

Open Access
Vaccines
vaccines
stakeholders
markets
Public-Private Sector Partnerships
Open Access
product development
Microbiota
Probiotics
Industry
Public-Private Sector Partnerships
Open Access
innovation
ecosystem
information technology
occupation
stakeholder

Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective

van der Waal, M. B., Flach, J., Browne, P. D., Besseling-van der Vaart, I., Claassen, E. & van de Burgwal, L. H. M., Mar 2019, In : PharmaNutrition. 7, p. 1-14 14 p., 100139.

Research output: Contribution to JournalArticleAcademicpeer-review

colitis
Probiotics
quality of life
Ulcerative Colitis
probiotics

The Nagoya Protocol on Access to Genetic Resources and Benefit Sharing: Best practices for users of Lactic Acid Bacteria

Flach, J., dos S. Ribeiro, C., van der Waal, M. B., van der Waal, R. X., Claassen, E. & van de Burgwal, L. H. M., Sep 2019, In : PharmaNutrition. 9, p. 1-6 6 p., 100158.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access
genetic resources
Practice Guidelines
lactic acid bacteria
Lactic Acid
Bacteria